CN114668680A - Washing-free quick-drying hand disinfectant capable of killing viruses - Google Patents
Washing-free quick-drying hand disinfectant capable of killing viruses Download PDFInfo
- Publication number
- CN114668680A CN114668680A CN202210249795.4A CN202210249795A CN114668680A CN 114668680 A CN114668680 A CN 114668680A CN 202210249795 A CN202210249795 A CN 202210249795A CN 114668680 A CN114668680 A CN 114668680A
- Authority
- CN
- China
- Prior art keywords
- test
- killing
- disinfectant
- hydrogen peroxide
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000645 desinfectant Substances 0.000 title claims abstract description 40
- 230000002147 killing effect Effects 0.000 title claims abstract description 30
- 241000700605 Viruses Species 0.000 title claims abstract description 28
- 238000001035 drying Methods 0.000 title claims abstract description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 57
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 42
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 36
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000008367 deionised water Substances 0.000 claims abstract description 15
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 15
- 239000004310 lactic acid Substances 0.000 claims abstract description 12
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 12
- 230000002195 synergetic effect Effects 0.000 claims abstract description 11
- 229960004106 citric acid Drugs 0.000 claims abstract description 5
- 235000015165 citric acid Nutrition 0.000 claims abstract description 5
- 229960000448 lactic acid Drugs 0.000 claims abstract description 5
- 239000004287 Dehydroacetic acid Substances 0.000 claims abstract description 4
- 235000019258 dehydroacetic acid Nutrition 0.000 claims abstract description 4
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229940061632 dehydroacetic acid Drugs 0.000 claims abstract description 4
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 claims abstract description 4
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000004334 sorbic acid Substances 0.000 claims abstract description 4
- 235000010199 sorbic acid Nutrition 0.000 claims abstract description 4
- 229940075582 sorbic acid Drugs 0.000 claims abstract description 4
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 29
- 230000002779 inactivation Effects 0.000 abstract description 11
- 229960005486 vaccine Drugs 0.000 abstract description 9
- 241000709701 Human poliovirus 1 Species 0.000 abstract description 4
- 230000000531 effect on virus Effects 0.000 abstract description 2
- 239000003973 paint Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 48
- 238000005070 sampling Methods 0.000 description 12
- 230000001954 sterilising effect Effects 0.000 description 12
- 241000991587 Enterovirus C Species 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 230000003472 neutralizing effect Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 239000003085 diluting agent Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 6
- 229920000053 polysorbate 80 Polymers 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000002452 interceptive effect Effects 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- 238000006386 neutralization reaction Methods 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 4
- 235000019345 sodium thiosulphate Nutrition 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 229920001503 Glucan Polymers 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000013095 identification testing Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 239000012137 tryptone Substances 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 241001478240 Coccus Species 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241001103617 Pseudomonas aeruginosa ATCC 15442 Species 0.000 description 1
- 239000006159 Sabouraud's agar Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012449 sabouraud dextrose agar Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
The invention discloses a washing-free hand-drying disinfectant capable of killing viruses, belonging to the technical field of disinfection. The paint consists of the following components in percentage by weight: 73-82% of ethanol, 0.1-0.16% of hydrogen peroxide, 0.5-2.0% of glycerol, 0.02-1% of synergistic component and the balance of deionized water, wherein the synergistic component is one or more selected from dehydroacetic acid, sorbic acid, citric acid and lactic acid. Acts for 1 minute according to the requirements of 'disinfection and sanitation Specification', has an average inactivation logarithm value of 4 for poliovirus type 1 vaccine strains, and has good inactivation effect on viruses.
Description
Technical Field
The invention relates to the technical field of disinfection, in particular to a washing-free quick-drying hand disinfectant capable of killing viruses.
Background
The hand washing is always an important thing in life, from the previous hand washing before meals to the current people traveling by public transport, the chances of contacting other people or objects are greatly increased, and the chances of disease infection through hands are also increased. The hand washing and sterilizing mode is from the prior soap and perfumed soap to the prior hand washing liquid, the washing effect is better and more, and the use is more and more convenient. Later, the no-clean liquid soap appeared, which does not need to use towels, water sources, soaps and the like, is convenient to carry and use and is gradually accepted by people. The main component of the no-clean quick-drying hand disinfectant capable of killing virus is usually ethanol, such as a classic no-clean quick-drying hand disinfectant capable of killing virus consisting of ethanol, hydrogen peroxide and glycerol.
In the prior art, high-concentration ethanol (such as about 75 percent) can be used for preparing a washing-free quick-drying hand disinfectant capable of killing viruses, and for example, a patent with the application number of CN202010380388.8 discloses a preparation method of a polysaccharide quick-drying hand disinfectant, which comprises the following components in parts by weight: 80ml of ethanol; 0.4ml of hydrogen peroxide; 0.1g of glucan quaternary ammonium salt; 1.5ml of glycerol; 18ml of purified water. In the patent, the quaternary ammonium salt of glucan is used as a disinfectant and a skin care component, and the quaternary ammonium glucan is applied to the hand disinfectant, so that the disinfection performance can be improved, and the effects of preventing bacteria and viruses from diffusing, protecting the skin and the like can be achieved.
Common disinfectant liquid formed by combining ethanol, hydrogen peroxide and glycerol acts for 1 minute according to the requirements of disinfection sanitation standards, and the killing logarithm value of the virus is 2-3, so that the high-efficiency disinfection effect cannot be achieved.
Disclosure of Invention
In order to solve the problems, the embodiment of the invention provides a washing-free quick-drying hand disinfectant capable of killing viruses, which has an average inactivation log value of 4 for poliovirus type 1 vaccine strains and a good virus inactivation effect. The technical scheme is as follows:
the embodiment of the invention provides a washing-free quick-drying hand disinfectant capable of killing viruses, which comprises the following components in percentage by weight: 73-82% of ethanol, 0.1-0.16% of hydrogen peroxide, 0.5-2.0% of glycerol, 0.02-1% of synergistic component and the balance of deionized water. Wherein, the synergistic component is selected from one or more of dehydroacetic acid, sorbic acid, citric acid, lactic acid and the like, and is preferably citric acid or lactic acid.
Preferably, the no-clean quick-drying hand sanitizer capable of killing viruses in the embodiment of the invention comprises the following components in percentage by weight: 73-82% of ethanol, 0.1-0.16% of hydrogen peroxide, 0.5-2.0% of glycerol, 0.07-0.3% of synergistic component and the balance of deionized water. Wherein the synergistic component is selected from one or more of citric acid and lactic acid.
More preferably, the no-clean quick-drying hand sanitizer capable of killing viruses in the embodiment of the present invention is composed of the following components by weight: 75% of ethanol, 0.1% of hydrogen peroxide, 1.0% of glycerol, 0.25% of citric acid and the balance of deionized water.
More preferably, the no-clean quick-drying hand sanitizer capable of killing viruses in the embodiment of the present invention is composed of the following components by weight: 78.7% of ethanol, 0.14% of hydrogen peroxide, 1.45% of glycerol, 0.21% of lactic acid and the balance of deionized water.
The disinfectant provided by the invention has the following beneficial effects:
(1) acts for 1 minute according to the requirements of disinfection and sanitation standards, has an average inactivation logarithm value of more than 4 for the poliovirus type 1 vaccine strain, and has good inactivation effect on viruses. Under the same conditions, the combination of ethanol, hydrogen peroxide and glycerol has a killing logarithm value of 2-3, and citric acid, lactic acid and the like have no killing effect on poliovirus type 1 vaccine strains.
(2) The disinfectant can kill intestinal pathogenic bacteria, pyogenic coccus, pathogenic yeast, nosocomial infection common bacteria, etc.
(3) The disinfectant can inactivate virus under hand cleaning condition.
(4) The added synergistic components do not affect the stability of the hydrogen peroxide.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, embodiments of the present invention are described in further detail below.
Example one
The no-clean quick-drying hand sanitizer capable of killing viruses in the first embodiment comprises the following components in percentage by weight: 78.7% of ethanol, 0.14% of hydrogen peroxide, 1.45% of glycerol, 0.21% of lactic acid and the balance of deionized water.
Example two
The no-clean quick-drying hand sanitizer capable of killing viruses in the second embodiment comprises the following components in percentage by weight: 75% of ethanol, 0.1% of hydrogen peroxide, 1.0% of glycerol, 0.25% of citric acid and the balance of deionized water.
EXAMPLE III
The no-clean quick-drying hand sanitizer capable of killing viruses in the third embodiment comprises the following components in percentage by weight: 80% of ethanol, 0.15% of hydrogen peroxide, 0.8% of glycerol, 0.5% of sorbic acid and the balance of deionized water.
Example four
The no-clean quick-drying hand sanitizer capable of killing viruses in the fourth embodiment comprises the following components in percentage by weight: 78.5% of ethanol, 0.135% of hydrogen peroxide, 1.0% of glycerol, 0.7% of dehydroacetic acid and the balance of deionized water.
Verification example, the disinfectant provided in example 1 was used for all the tests.
First, sterilization test
1.1. Test strains: escherichia coli 8099, Staphylococcus aureus ATC6538 and Pseudomonas aeruginosa ATCC15442 were provided by food safety culture Collection of food microbial safety engineering research and development center of Guangdong province, and their 5 th generation fresh slant culture was used for the test.
1.2. Neutralizing agent: 3% Tween 80+0.3% lecithin +0.1% sodium thiosulfate in 0.03mol/L PBS.
1.3. Culture medium: tryptone soy agar medium.
1.4. Organic interfering substances: 3% BSA solution.
1.5. The method comprises the following steps: according to specification on disinfection (2002 edition) 2.1.1.5, 2.1.1.7. Neutralization test: the test bacteria is Escherichia coli, the sterilization time is 0.5min, the test environment temperature is 19-21 deg.C, the relative humidity is 45-60%, and the test is repeated for 3 times. And (3) sterilization test: sterilizing with disinfectant, testing at 19-21 deg.C and 45-60% relative humidity, and repeating for 3 times. The incubation temperature was 37 ℃.
1.6. Positive control: the test procedure was followed using sterile diluent instead of test solution.
1.7. Coli neutralizer identification test, the results are shown in table 1:
TABLE 1
As can be seen from table 1: the average number of recovered bacteria in group 1 was 0CFU/mL, and the average number of recovered bacteria in group 2 was 207 CFU/mL. Therefore, the disinfectant has a killing effect on escherichia coli, and the disinfectant and a neutralization product have no adverse effect on the escherichia coli.
1.8. Killing test of test bacteria: the test environment temperature is 19-21 ℃, the test is repeated for 3 times, the killing logarithm values of the disinfectant on escherichia coli, staphylococcus aureus and pseudomonas aeruginosa are all more than 5.00 after the disinfectant is respectively acted for 0.5min, 1min and 1.5min, and the results are shown in tables 2-4:
TABLE 2
TABLE 3
TABLE 4
Second, fungus killing test (suspension method)
2.1. Test strains: candida albicans (ATCC 10231) provided by food safety culture collection of research and development center of food and microorganism safety engineering, Guangdong province, and its 5 th generation fresh slant culture was used for testing.
2.2. Neutralizing agent: 3% Tween 80+0.3% lecithin +0.1% sodium thiosulfate in 0.03mol/L PBS.
2.3. Culture medium: sabouraud agar medium.
2.4. Organic interfering substances: 3% BSA solution.
2.5. The method comprises the following steps: according to specification on disinfection (2002 edition) 2.1.1.5, 2.1.1.9. And (3) neutralization test: the sterilization time is 0.5min, the test environment temperature is 19-21 ℃, the relative humidity is 45-60%, and the test is repeated for 3 times. And (3) sterilization test: sterilizing with disinfectant, testing at 19-21 deg.C and 45-60% relative humidity, and repeating for 3 times. The incubation temperature was 37 ℃.
2.6. Positive control: the test procedure was followed using sterile diluent instead of test solution. The results are shown in Table 5:
TABLE 5
As can be seen from table 5: the average number of recovered bacteria in group 1 was 0CFU/mL, the average number of recovered bacteria in group 2 was 450CFU/mL, and group 6 was grown aseptically.
2.7. The killing effect on experimental bacteria is as follows: the experimental environment temperature is 19-21 ℃, the experiment is repeated for 3 times, the killing log values of the disinfectant on the candida albicans are all more than 5.00 in 0.5min, 1min and 1.5min, and the results are shown in table 6:
TABLE 6
Thirdly, the disinfectant is tested on the hand disinfection site (sanitary hand)
3.1. Neutralizing agent: 3% Tween 80+0.3% lecithin +0.1% sodium thiosulfate in 0.03mol/L PBS.
3.2. Diluent agent: 0.03mol/L phosphate buffer solution of 0.1% Tween 80, pH 7.2.
3.3. Culture medium: tryptone soy agar medium.
3.4. The method comprises the following steps: according to specification on Sterilization (2002 edition) 2.1.2.6. And (3) disinfection test: using disinfectant as a use sample, wiping and disinfecting for 1min, wherein the test environment temperature is 19-21 ℃, and the relative humidity is 45-60%. A subject: two hands (sanitary hands) of 30 volunteers were sampled from the left hand before sterilization to serve as a positive control group, and the samples were applied to the right hand of the volunteer for 1min and then the samples were used as a test group. The sampling method comprises the following steps: and (3) wiping the sterile cotton swab in a sampling liquid test tube for wetting, smearing and sampling the positive control group and the disinfection test group, cutting a sampling end of the cotton swab into 10mL of sampling liquid in a sterile mode, and eluting. Negative control: directly culturing the sampling solution and the diluent in the same batch. The results are shown in Table 7:
TABLE 7
As can be seen from the results in Table 7, the average killing log value is greater than 1.80, which meets the requirements of the Disinfection technical Specification, and the average killing log value is greater than 1.00.
Fourth, the disinfectant is tested on the hand disinfection field (surgical hand)
4.1. Neutralizing agent: 3% Tween 80+0.3% lecithin +0.1% sodium thiosulfate in 0.03mol/L PBS.
4.2. Diluent (b): 0.03mol/L phosphate buffer solution of 0.1% Tween 80, pH 7.2.
4.3. Culture medium: tryptone soy agar medium.
4.4. The method comprises the following steps: according to specification on Sterilization (2002 edition) 2.1.2.6. And (3) disinfection test: using disinfectant as a use sample, wiping and disinfecting for 3min, wherein the test environment temperature is 19-21 ℃, and the relative humidity is 45-60%. A subject: two hands (surgical hands) of 30 volunteers were sampled from the left hand before sterilization to serve as a positive control group, and the samples were applied to the right hand of the volunteer for 3min and then used as a test group. The sampling method comprises the following steps: and (3) wiping the sterile cotton swab in a sampling liquid test tube for wetting, smearing and sampling the positive control group and the disinfection test group, cutting a sampling end of the cotton swab into 10mL of sampling liquid in a sterile mode, and eluting. Negative control: directly culturing the sampling solution and the diluent in the same batch. The results are shown in Table 8:
TABLE 8
As can be seen from the results in Table 8, the average kill log value is greater than 1.88, which meets the requirements of the Disinfection technical Specification, and the average kill log value is greater than 1.00.
Fifthly, quantitative inactivation test of poliovirus suspension
First, equipment
1. Test virus strains: poliovirus type I (PV-I) vaccine strain.
2. Host cell: VERO cells.
3. The disinfectant of example 1.
4. Neutralizing agent: D/E neutralizes the broth.
5. Cell culture bottles and 96-well culture plates.
6. Organic interfering substances: 0.3% bovine serum albumin.
7. Standard hard water (hardness 342 mg/L).
8. Cell maintenance medium, cell complete medium and fetal bovine serum.
9. A thermostat, a carbon dioxide incubator, a biological safety cabinet, an adjustable pipettor and sterile equipment.
Second, method
1. The detection basis is as follows: specification for Disinfection (2002 edition) 2.1.1.10.5 and 2.1.1.10.7.
2. Preparation of virus suspension: titer for the assay was 106TCID50/0.1mL-107TCID500.1mL ridgeThe poliovirus I type vaccine strain virus suspension is diluted in duplicate with 0.3% bovine serum albumin organic interfering substance, and is placed at a constant temperature of 20 ℃ for later use.
3. And (3) identification test of a neutralizer: the disinfectant is acted for 0.5min, and the test temperature is constant at 20 ℃. The experiment was repeated 3 times.
4. Virus inactivation test: the disinfectant solution is applied for 0.5min, 1.0min and 1.5 min. The test temperature was a constant temperature of 20 ℃. The test was repeated 3 times.
5. Detecting the ambient temperature: 20.5-21.0 ℃; relative humidity: 10 to 44 percent.
Three, result in
1. Neutralizer identification test
After 3 times of repeated tests, under the condition of a constant temperature test at 20 ℃, the identification result of the disinfectant neutralizer is as follows: the average titer value of the group 1 virus was 0.78, the average titer value of the group 2 virus was 2.50, the average titer values of the group 3, group 4 and group 5 viruses were 6.94, 6.78 and 7.11, respectively, and the group 6 was a negative control group, and the results are shown in table 9:
TABLE 9
2. Inactivating effect on poliovirus
After 3 repeated tests, under the condition of a constant temperature test at 20 ℃, the disinfectant is applied for 1.0min, the average inactivation log value of the poliovirus is more than 4.00, and the results are shown in table 10:
watch 10
Fourth, conclusion
1. After 3 times of repeated tests, under the condition of a constant temperature test at 20 ℃, the neutralizing agent solution of the D/E neutralizing broth can effectively neutralize the residual action of the disinfectant on the poliovirus type I vaccine strain, and the neutralizing agent and a neutralization product basically have no influence on the growth of the poliovirus type I vaccine strain and cells.
2. After repeated tests for 3 times, under the condition of a constant temperature test at 20 ℃, the disinfection solution is applied for 1.0min, and the average inactivation log value of the poliovirus type I vaccine strain is more than 4.00.
Sixthly, measuring the stability of the hydrogen peroxide (chemical method)
First, equipment
1. Sample preparation: the disinfectant of example 1.
2. An instrument device: 25mL brown polytetrafluoro burette, volumetric flask, etc., Shanghai Bo news SPX-250B-Z constant temperature incubator.
3. The concentration of potassium permanganate standard titration solution is 0.0200 mol/L.
Second, method
1. The detection basis is as follows: specification for Disinfection (2002 edition) 2.2.3.2 and 2.2.1.2.4.
2. Storage conditions are as follows: the sample was well sealed and placed in a 37 ℃ incubator for 3 months (90 d).
3. The test environment temperature is 20.5 ℃, and the relative humidity is 65.0%.
Three, result in
One sample batch was tested twice for each batch and the results are shown in table 11:
TABLE 11
The content of the effective component hydrogen peroxide before preservation is 0.140%, the content of the effective component hydrogen peroxide after preservation is 0.133%, and the content reduction rate of the hydrogen peroxide is 5% after the preservation for 3 months at 37 ℃.
Comparative example 1
The no-clean quick-drying hand sanitizer of comparative example 1 consists of the following components in percentage by weight: 78.7% of ethanol, 0.14% of hydrogen peroxide, 1.45% of glycerol and the balance of deionized water.
Comparative example 2
The no-clean quick-drying hand sanitizer of comparative example 2 consists of the following components in percentage by weight: 75% of ethanol, 0.1% of hydrogen peroxide, 1.0% of glycerol and the balance of deionized water.
The effects of examples 1-2 and comparative examples 1-2 were verified using the aforementioned poliovirus suspension quantitative inactivation assay, with an action time of 1.0 min. The results are shown in Table 12:
TABLE 12
In addition, through tests, the citric acid or the lactic acid has no killing effect on the poliovirus basically; therefore, the citric acid or lactic acid can improve the effect of killing poliovirus when being matched with the conventional quick-drying hand disinfectant.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (4)
1. A washing-free hand-drying disinfectant capable of killing viruses is characterized by comprising the following components in percentage by weight: 73-82% of ethanol, 0.1-0.16% of hydrogen peroxide, 0.5-2.0% of glycerol, 0.02-1% of synergistic component and the balance of deionized water, wherein the synergistic component is one or more selected from dehydroacetic acid, sorbic acid, citric acid and lactic acid.
2. The virus-killing no-clean hand-drying disinfectant as claimed in claim 1, which is prepared from the following components in percentage by weight: 73-82% of ethanol, 0.1-0.16% of hydrogen peroxide, 0.5-2.0% of glycerol, 0.07-0.3% of synergistic component and the balance of deionized water, wherein the synergistic component is selected from one or more of citric acid and lactic acid.
3. The virus-killing no-clean hand-drying disinfectant as claimed in claim 1, which is prepared from the following components in percentage by weight: 75% of ethanol, 0.1% of hydrogen peroxide, 1.0% of glycerol, 0.25% of citric acid and the balance of deionized water.
4. The virus-killing no-clean hand-drying disinfectant as claimed in claim 1, which is prepared from the following components in percentage by weight: 78.7% of ethanol, 0.14% of hydrogen peroxide, 1.45% of glycerol, 0.21% of lactic acid and the balance of deionized water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210249795.4A CN114668680A (en) | 2022-03-15 | 2022-03-15 | Washing-free quick-drying hand disinfectant capable of killing viruses |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210249795.4A CN114668680A (en) | 2022-03-15 | 2022-03-15 | Washing-free quick-drying hand disinfectant capable of killing viruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114668680A true CN114668680A (en) | 2022-06-28 |
Family
ID=82074833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210249795.4A Pending CN114668680A (en) | 2022-03-15 | 2022-03-15 | Washing-free quick-drying hand disinfectant capable of killing viruses |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114668680A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108077305A (en) * | 2017-11-24 | 2018-05-29 | 中国人民解放军陆军防化学院 | Hydrogen peroxide Compositional type disinfectant, application method and application |
| US20180184650A1 (en) * | 2017-01-02 | 2018-07-05 | Jeffrey A. Greene | Hydrogen Peroxide Sanitizing Cleaner |
| JP2019073453A (en) * | 2017-10-12 | 2019-05-16 | Ｍｃフードスペシャリティーズ株式会社 | Antimicrobial composition which suppresses viruses, bacteria, and fungi |
| CN111228304A (en) * | 2020-03-11 | 2020-06-05 | 山东名德医疗科技有限公司 | Virus-killing hand-washing-free disinfectant and preparation method thereof |
| CN112514913A (en) * | 2019-09-18 | 2021-03-19 | 上海利康消毒高科技有限公司 | Hydrogen peroxide disinfectant and preparation method thereof |
-
2022
- 2022-03-15 CN CN202210249795.4A patent/CN114668680A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180184650A1 (en) * | 2017-01-02 | 2018-07-05 | Jeffrey A. Greene | Hydrogen Peroxide Sanitizing Cleaner |
| JP2019073453A (en) * | 2017-10-12 | 2019-05-16 | Ｍｃフードスペシャリティーズ株式会社 | Antimicrobial composition which suppresses viruses, bacteria, and fungi |
| CN108077305A (en) * | 2017-11-24 | 2018-05-29 | 中国人民解放军陆军防化学院 | Hydrogen peroxide Compositional type disinfectant, application method and application |
| CN112514913A (en) * | 2019-09-18 | 2021-03-19 | 上海利康消毒高科技有限公司 | Hydrogen peroxide disinfectant and preparation method thereof |
| CN111228304A (en) * | 2020-03-11 | 2020-06-05 | 山东名德医疗科技有限公司 | Virus-killing hand-washing-free disinfectant and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 王玲;刘起展;冷红英;褚宏亮;: "不同种类手消毒剂对脊髓灰质炎病毒灭活效果的实验观察", 中国消毒学杂志, no. 02, pages 106 - 107 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Selkon et al. | Evaluation of the antimicrobial activity of a new super-oxidized water, Sterilox®, for the disinfection of endoscopes | |
| Blaser et al. | Inactivation of Campylobacter jejuni by chlorine and monochloramine | |
| JP6803896B2 (en) | Antimicrobial agent containing hypochlorous acid | |
| CN101766552A (en) | Washing-free antibacterial hand sanitizer and preparation method thereof | |
| Collins et al. | Mycobactericidal activity of glutaraldehyde solutions | |
| CN108605933B (en) | Fatty acid compound | |
| CN111671709A (en) | Tea tree essential oil and ethanol double-disinfection and washing-free hand sanitizer and preparation method thereof | |
| CN112022732A (en) | Hand-washing-free disinfectant and preparation method thereof | |
| CN112741087A (en) | Cold chain food disinfectant and preparation method thereof | |
| CN113287627A (en) | Cleaning disinfectant containing potassium hydrogen persulfate compound, and use method and application thereof | |
| CN108477209A (en) | A kind of thimerosal and preparation method thereof | |
| CN113142240A (en) | Environment disinfectant and preparation method thereof | |
| Bartlett et al. | Surfactant-iodine complexes as germicides | |
| CN111418602A (en) | No-clean disinfectant and preparation method and application thereof | |
| CN101646340B (en) | Production of a viable, storable worm egg suspension | |
| Chander et al. | Antiviral activity of Ecasol against feline calicivirus, a surrogate of human norovirus | |
| Coates et al. | Sporicidal activity of mixtures of alcohol and hypochlorite. | |
| CN114668680A (en) | Washing-free quick-drying hand disinfectant capable of killing viruses | |
| CN109620743B (en) | Mouthwash containing acidic bactericide and preparation method thereof | |
| CN104886110B (en) | A kind of multiduty composite cation surfactant disinfectants | |
| CN112868665B (en) | Disinfectant containing supermolecule silver and preparation method thereof | |
| US6506417B1 (en) | Composition and process for reducing bacterial citrus canker organisms | |
| CN113144177A (en) | Surface sterilization antiviral spray and preparation method and application thereof | |
| CN114208845B (en) | Hypochlorous acid disinfectant and preparation method and application thereof | |
| CN112972281A (en) | Disinfectant-grade hand sanitizer containing salicylic acid microcapsules and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220628 |